Difficulty: Medium
Correct Answer: Using chemically synthesized DNA sequences for the A and B chains separately (expressed as fusion proteins and then recombined)
Explanation:
Introduction / Context:Recombinant human insulin was produced using early bacterial expression strategies that overcame challenges of peptide stability and processing. Understanding the chain-by-chain method explains how bioidentical insulin was obtained without relying on animal pancreases.
Given Data / Assumptions:
Concept / Approach:One classic strategy used two synthetic genes (for A and B chains). Each chain was expressed in E. coli as a β-galactosidase fusion, cleaved with cyanogen bromide, purified, and then oxidatively refolded together to form native disulfide bonds. Alternative approved methods later used proinsulin cDNA with enzymatic processing, but the chain-by-chain method is historically significant and matches the option given.
Step-by-Step Solution:
Chemically synthesize DNA for A and B chains.Express each as a stable fusion in E. coli.Cleave fusions (e.g., CNBr at Met), purify chains.Reconstitute A+B with correct disulfide formation to yield insulin.Verification / Alternative check:Regulatory and historical accounts of Humulin describe chain-by-chain and proinsulin strategies; both yield bioidentical insulin but the option specifying separate chain synthesis matches the classic approach.
Why Other Options Are Wrong:
Common Pitfalls:Assuming bacteria can process preprohormones like human cells; engineered strategies are required to obtain mature insulin.
Final Answer:Using chemically synthesized DNA sequences for the A and B chains separately (expressed as fusion proteins and then recombined).
Discussion & Comments